David Barger, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 436 Central Ave W, Jamestown, TN 38556 Phone: 931-879-8171 |
Joseph Payant, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 S Duncan St, Jamestown, TN 38556 Phone: 931-839-5864 Fax: 931-879-3903 |
Dr. Patricia B Meisner, D.O., FACEP Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 208 Central Ave W, Jamestown, TN 38556 Phone: 865-305-9401 Fax: 931-879-3290 |
Dr. Richard Gary Clark, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 S Duncan St, Jamestown, TN 38556 Phone: 931-879-5864 Fax: 931-879-3903 |
News Archive
Forbes examines the ongoing discussions between aid groups and drug manufacturers over the formation of an HIV/AIDS drugs patent pool to help drive down costs for developing countries.
Can cancer patients tap into a certain kind of hope that is often overlooked but incredibly therapeutic and healing? Research by University Distinguished Professor of Marketing Leonard Berry of Texas A&M University's Mays Business School suggests clinicians can help patients tap into this kind of hope.
This issue includes a feature on designer DNA-binding proteins to combat viral infections in agriculture and medicine; news items include updates of official opening of the Okayama University Silicon Valley Office at Fremont (CA), and international collaboration work with Xiamen University; research highlights on immunizing plants; identification of gene Vrn-D4 for enabling wheat to adapt to areas with warm winters; importance of introgression on intra-specific genetic differentiation and adaptive divergence; an interesting twist on supercooled liquid water; and manufacturing denim in Okayama.
Recent evidence demonstrates that the origins of photosynthesis can be found in deep sea hydrothermal vents, where microbes evolved to obtain energy from ejected hydrogen sulfide and methane gases.
Increasingly, Big Pharma is betting on new blockbuster cancer drugs that cost billions to develop and can be sold for thousands of dollars a dose. In 2010, each of the top 10 cancer drugs topped more than $1 billion in sales, according to Campbell Alliance, a health-care consulting firm. A decade earlier, only two of them did.
› Verified 4 days ago